Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Search by expertise, name or affiliation
The impact of antileukotriene therapy on markers of airway inflammation
W. J. Calhoun
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The impact of antileukotriene therapy on markers of airway inflammation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Asthma
100%
Airway Inflammation
100%
Zafirlukast
100%
Anti-leukotriene Therapy
100%
Bronchoalveolar Lavage Fluid
75%
Antileukotrienes
75%
Airway
50%
Alveolar Macrophages
50%
Inflammatory Cells
50%
Allergen Challenge
50%
Basophils
50%
Segmental Allergen Challenge
50%
Inflammation
25%
Placebo
25%
Lung
25%
Inflammatory Mediators
25%
Histamine
25%
Eosinophils
25%
Infiltration
25%
Inhaled Corticosteroids
25%
Eosinophilia
25%
Inflammatory Conditions
25%
Superoxide Release
25%
Anti-inflammatory Effect
25%
Superoxide Production
25%
Zileuton
25%
5-lipoxygenase Inhibitors
25%
Cysteinyl Leukotrienes
25%
Controller Medication
25%
Nocturnal Asthma
25%
Cysteinyl Leukotriene Receptor 2 (CysLT2R)
25%
Maintenance Medication
25%
Immunology and Microbiology
Allergen
100%
Asthma
100%
Zafirlukast
100%
Bronchoalveolar Lavage Fluid
75%
Antileukotriene Agents
75%
Alveolar Macrophage
50%
Inflammatory Cell
50%
Basophil Granulocyte
50%
Superoxide
50%
Peptidoleukotriene
50%
Mediator
25%
Eosinophil Granulocyte
25%
Antiinflammatory Activity
25%
Leukotriene Antagonist
25%
Nocturnal Asthma
25%
Zileuton
25%
Histamine
25%
Pharmacology, Toxicology and Pharmaceutical Science
Respiratory Tract Inflammation
100%
Zafirlukast
100%
Antileukotriene Agent
100%
Asthma
80%
Allergen
80%
Inflammation
40%
Superoxide
40%
Peptidoleukotriene
40%
Placebo
20%
Eosinophilia
20%
Histamine
20%
Lipoxygenase Inhibitor
20%
Antiinflammatory Activity
20%
Zileuton
20%
Leukotriene Receptor Blocking Agent
20%
Nocturnal Asthma
20%